Blepharitis surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
[[Surgical|Surgical intervention]] is not the first-line treatment option for patients with blepharitis.<ref name="pmid24043929">{{cite journal| author=Qiao J, Yan X| title=Emerging treatment options for meibomian gland dysfunction. | journal=Clin Ophthalmol | year= 2013 | volume= 7 | issue= | pages= 1797-803 | pmid=24043929 | doi=10.2147/OPTH.S33182 | pmc=3772773 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24043929 }} </ref><ref name="pmid21450919">{{cite journal| author=Geerling G, Tauber J, Baudouin C, Goto E, Matsumoto Y, O'Brien T et al.| title=The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. | journal=Invest Ophthalmol Vis Sci | year= 2011 | volume= 52 | issue= 4 | pages= 2050-64 | pmid=21450919 | doi=10.1167/iovs.10-6997g | pmc=3072163 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21450919 }} </ref> | [[Surgical|Surgical intervention]] is not the first-line treatment option for patients with blepharitis.<ref name="pmid24043929">{{cite journal| author=Qiao J, Yan X| title=Emerging treatment options for meibomian gland dysfunction. | journal=Clin Ophthalmol | year= 2013 | volume= 7 | issue= | pages= 1797-803 | pmid=24043929 | doi=10.2147/OPTH.S33182 | pmc=3772773 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24043929 }} </ref><ref name="pmid21450919">{{cite journal| author=Geerling G, Tauber J, Baudouin C, Goto E, Matsumoto Y, O'Brien T et al.| title=The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. | journal=Invest Ophthalmol Vis Sci | year= 2011 | volume= 52 | issue= 4 | pages= 2050-64 | pmid=21450919 | doi=10.1167/iovs.10-6997g | pmc=3072163 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21450919 }} </ref> | ||
==Surgery== | ==Surgery== | ||
Surgical intervention for blepharitis is usually reserved for the patients with complications, such as [[chalazion]], [[entropion]], [[ectropion]], or horizontal eyelid laxity.<ref name="pmid24043929">{{cite journal| author=Qiao J, Yan X| title=Emerging treatment options for meibomian gland dysfunction. | journal=Clin Ophthalmol | year= 2013 | volume= 7 | issue= | pages= 1797-803 | pmid=24043929 | doi=10.2147/OPTH.S33182 | pmc=3772773 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24043929 }} </ref><ref name="pmid21450919">{{cite journal| author=Geerling G, Tauber J, Baudouin C, Goto E, Matsumoto Y, O'Brien T et al.| title=The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. | journal=Invest Ophthalmol Vis Sci | year= 2011 | volume= 52 | issue= 4 | pages= 2050-64 | pmid=21450919 | doi=10.1167/iovs.10-6997g | pmc=3072163 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21450919 }} </ref> | Surgical intervention for blepharitis is usually reserved for the patients with complications, such as [[chalazion]], [[entropion]], [[ectropion]], or horizontal eyelid laxity.<ref name="pmid24043929">{{cite journal| author=Qiao J, Yan X| title=Emerging treatment options for meibomian gland dysfunction. | journal=Clin Ophthalmol | year= 2013 | volume= 7 | issue= | pages= 1797-803 | pmid=24043929 | doi=10.2147/OPTH.S33182 | pmc=3772773 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24043929 }} </ref><ref name="pmid21450919">{{cite journal| author=Geerling G, Tauber J, Baudouin C, Goto E, Matsumoto Y, O'Brien T et al.| title=The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. | journal=Invest Ophthalmol Vis Sci | year= 2011 | volume= 52 | issue= 4 | pages= 2050-64 | pmid=21450919 | doi=10.1167/iovs.10-6997g | pmc=3072163 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21450919 }} </ref> | ||
Revision as of 15:48, 14 July 2016
|
Blepharitis Microchapters | |
|
Diagnosis | |
|---|---|
|
Treatment | |
|
Case Studies | |
|
Blepharitis surgery On the Web | |
|
American Roentgen Ray Society Images of Blepharitis surgery | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]
Overview
Surgical intervention is not the first-line treatment option for patients with blepharitis.[1][2]
Surgery
Surgical intervention for blepharitis is usually reserved for the patients with complications, such as chalazion, entropion, ectropion, or horizontal eyelid laxity.[1][2]
Intraductal Meibomian Gland Probing
Invasive orifice penetration and intraductal probing seems to provide lasting rapid symptom relief for patients with posterior blepharitis and meibomian gland dysfunction (MGD).[3]
Lipiflow sysytem
LipiFlow, thermal pulsation system, gave rise to significant improvement in both signs and symptoms of patients with meibomian gland dysfunction. LipiFlow provides heat and gentle pressure on the eyelid to liquefy and release obstructions in the meibomian glands.[4]
References
- ↑ 1.0 1.1 Qiao J, Yan X (2013). "Emerging treatment options for meibomian gland dysfunction". Clin Ophthalmol. 7: 1797–803. doi:10.2147/OPTH.S33182. PMC 3772773. PMID 24043929.
- ↑ 2.0 2.1 Geerling G, Tauber J, Baudouin C, Goto E, Matsumoto Y, O'Brien T; et al. (2011). "The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction". Invest Ophthalmol Vis Sci. 52 (4): 2050–64. doi:10.1167/iovs.10-6997g. PMC 3072163. PMID 21450919.
- ↑ Maskin SL (2010). "Intraductal meibomian gland probing relieves symptoms of obstructive meibomian gland dysfunction". Cornea. 29 (10): 1145–52. doi:10.1097/ICO.0b013e3181d836f3. PMID 20622668.
- ↑ Lane SS, DuBiner HB, Epstein RJ, Ernest PH, Greiner JV, Hardten DR; et al. (2012). "A new system, the LipiFlow, for the treatment of meibomian gland dysfunction". Cornea. 31 (4): 396–404. doi:10.1097/ICO.0b013e318239aaea. PMID 22222996.